Hyacorp Body Contouring MLF2 (1 × 10 mL) is a high-density, cross-linked hyaluronic acid dermal filler specifically developed for body contouring and large-volume soft tissue augmentation.
It is commonly used for shaping and volumizing areas such as the buttocks, hips, calves, and other body regions where substantial projection and firmness are required.
The formulation provides strong structural support and cohesive volume while allowing controlled placement in deeper tissue planes.
Clinical results typically last up to 12–18 months, depending on treatment area, injected volume, and individual metabolic factors.
Rheological properties / Product data
HA concentration: 20 mg/ml
Cross-linking agent: BDDE
Elasticity (G’): Very high
Cohesivity: High
Texture: Very firm HA gel
Lidocaine content: None
Packaging: 1 syringe × 10 ml
The high-density gel is engineered for large-volume body applications, offering durable projection and shape retention.
Injection depth & tools
Recommended depth: Deep subcutaneous tissue
Injection techniques: Bolus or fanning, adapted for large-volume placement
Recommended instruments: Large-gauge cannula
Inject slowly under strict aseptic conditions. Aspiration and anatomical knowledge are critical to minimize vascular and tissue risks.
Storage & handling
Store at room temperature (do not freeze)
Protect from direct sunlight
Single-use only — use immediately after opening
Do not use if packaging is damaged or expired
Dispose of syringes and cannulas according to medical waste regulations
For use by licensed medical professionals only. Not intended for self-injection.
Conservative volumes in indicated body planes; inject slowly; avoid intravascular placement.
Common: redness, swelling, bruising, tenderness. Rare but serious: vascular occlusion (blanching, severe pain, visual changes—urgent care required).
Cross‑linked HA restores volume and contour; integrates with surrounding tissue.
Avoid alcohol 24h before and after treatment—vasodilation increases bleeding/bruising and may slow recovery.
Not recommended in pregnancy—elective injectables lack robust safety data; defer until after delivery.
Not advised during breastfeeding—limited data on transfer via milk and infant safety; postpone elective procedures.
